Repligen (RGEN) Q3 2026 Earnings Call Transcript
· fool.com · popularity 43/100 · 6 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at fool.com →
Summary
BioLife acquisition bolsters cell therapy as chromatography and proteins surge. Image source: The Motley Fool. Tue, Oct. 27, 2026 CALL PARTICIPANTS Vice …
Found in: Innovation. Rating basis: 6 other outlets; outlet tier 2 (unlisted); 1 feeds; feed position 29.